NGEN

NervGen Pharma Corp.

Price

$2.11

return (12m)

-16.99%

p/e

-37.36

p/bv

64.98

DIVIDEND YIELD

0.00%

NGEN price

NervGen Pharma Corp.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NGEN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

16.57%

3 months

-4.09%

1 year

-16.99%

2 years

5.50%

5 years

37.19%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals NGEN

Valuation

P/E

-37.36

Sector 7.84

Industry 7.84

P/BV

64.98

Sector 1.84

Industry 1.84

P/Revenue (PSR)

Sector 1.78

Industry 1.78

EV/EBITDA

-82.88

Sector -57.74

Industry -57.74

EV/EBIT

-82.79

Sector -289.61

Industry -289.61

P/EBITDA

-88.83

Sector -9.38

Industry -9.38

P/EBIT

-88.90

Sector -9.71

Industry -9.71

P/Total Assets

12.45

Sector 0.86

Industry 0.86

P/Net Current Assets

2.52

Sector -2.04

Industry -2.04

P/Working Capital

11.53

Sector -4,847.72

Industry -4,847.72

EPS

-0.06

Sector 0.73

Industry 0.73

BVPS

0.03

Sector 9.89

Industry 9.89

Efficiency

Gross Margin

-100.00%

Sector 35.14%

Industry 35.14%

EBITDA Margin

-1,206,412,422.22%

Sector 7.88%

Industry 7.88%

EBIT Margin

-1,207,792,005.56%

Sector -7.02%

Industry -7.02%

Operating Margin

-100.00%

Sector 4.32%

Industry 4.32%

Net Profit Margins

-100.00%

Sector 2.76%

Industry 2.76%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-173.95%

Sector 2.49%

Industry 2.49%

ROA

-33.32%

Sector -0.64%

Industry -0.64%

ROIC

Sector -117.48%

Industry -117.48%

Dividends

Dividend yield

0.00%

Sector 0.50%

Industry 0.50%

Payout

Sector 9.69%

Industry 9.69%

Debt

Current Ratio

1.23

Sector 1.46

Industry 1.46

Net Debt / EBITDA

6.94

Sector -20.28

Industry -20.28

Net Debt / EBIT

6.94

Sector -165,634,871.06

Industry -165,634,871.06

Net Debt / Equity

-5.02

Sector -0.77

Industry -0.77

Gross Debt / Equity

0.00

Sector 0.06

Industry 0.06

Equity/Assets

0.19

Sector 0.43

Industry 0.43

Liabilities/Assets

0.81

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

25.59%

Sector -

Industry -

5Y Earnings CAGR

134.97%

Sector -

Industry -

Fundamentals NGEN

DRAG THE FRAME TO SEE MORE DATA

NGEN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT NervGen Pharma Corp.

NervGen Pharma Corp.

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2026

Time since IPO - 0 year

9

Employees

NervGen Pharma Corp. (United States) is listed on the Nasdaq and has a market capitalization of $195.06 million, with shareholders equity totaling $3.00 million.

The company employs approximately 9 people and operates in the Others sector, within the Others industry.

Over the past 12 months, NervGen Pharma Corp. reported $0.18 in revenue, generating net income of $-5.22 million.

Key financial metrics include a P/E ratio of -37.36, a price-to-book (P/B) ratio of 64.98, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NGEN.

Market cap

$195.06 million

Net worth

$3.00 million

$3,001,617.01

Assets

$15.67 million

$15,669,041.35

Total Shares Outstanding

92.44 million

92,443,000

Average Daily Trading Volume

$156.66 Thousand

$156,658.85

Sector

Others

Industry

Others

NGEN

NGEN revenue and profits

Financial Results NGEN

DRAG THE FRAME TO SEE MORE DATA

NGEN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$374.03 14,05% (12M)

P/E

22.48

2.41%

ROE

14.27%

P/BV

3.21

SHEL - Shell PLC ADR

$94.75 38,99% (12M)

P/E

10.11

3.98%

ROE

14.29%

P/BV

1.44

STLA - Stellantis NV

$4.82 --51,25% (12M)

P/E

-0.55

0.00%

ROE

-35.93%

P/BV

0.20

COR - Cencora Inc.

$307.93 6,98% (12M)

P/E

22.65

0.78%

ROE

81.08%

P/BV

18.36

ALIZY - Allianz SE ADR

$50.57 --9,44% (12M)

P/E

13.94

2.69%

ROE

17.89%

P/BV

2.49

TTE - TotalEnergies SE ADR

$90.89 58,75% (12M)

P/E

7.30

4.46%

ROE

21.42%

P/BV

1.56

NSRGY - Nestle SA ADR

$92.61 5,71% (12M)

P/E

11.12

4.33%

ROE

58.05%

P/BV

6.46

ELV - Elevance Health Inc

$407.90 32,76% (12M)

P/E

20.04

1.69%

ROE

9.84%

P/BV

1.97